Kevin C. Oboyle, Director at GenMark Diagnostics, Inc. (GNMK), bought 10,800 shares at $4.53 ($49K) on 2020-03-06, disclosed to the SEC on 2020-03-09.
Open-market purchase of $49k GNMK by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| SIEN | BUY | 2019-06-11 | $50K | — | Filing → |
| NVRO | BUY | 2019-06-07 | $101K | — | Filing → |
| WMGI | SELL | 2019-03-05 | $205K | — | Filing → |